tiprankstipranks
Co-Diagnostics Inc (CODX)
NASDAQ:CODX
US Market

Co-Diagnostics (CODX) Financial Statements

1,654 Followers

Co-Diagnostics Financial Overview

Co-Diagnostics's market cap is currently $5.84M. The company's EPS TTM is $-16.35; its P/E ratio is -0.14; Co-Diagnostics is scheduled to report earnings on March 31, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 622.49K$ 3.92M$ 6.81M$ 34.22M$ 97.89M
Gross Profit$ 400.11K$ 2.92M$ 2.63M$ 28.74M$ 86.31M
Operating Income$ -50.17M$ -40.08M$ -42.71M$ -26.98M$ 46.06M
EBITDA$ -47.41M$ -38.70M$ -41.48M$ -10.31M$ 46.40M
Net Income$ -46.90M$ -37.64M$ -35.33M$ -14.24M$ 36.66M
Balance Sheet
Cash & Short-Term Investments$ 11.88M$ 29.75M$ 58.55M$ 81.26M$ 89.86M
Total Assets$ 24.74M$ 64.00M$ 95.32M$ 123.09M$ 160.03M
Total Debt$ 1.24M$ 2.15M$ 2.99M$ 347.92K$ 0.00
Net Debt$ -10.65M$ -784.37K$ -11.93M$ -22.63M$ -88.61M
Total Liabilities$ 574.30K$ 9.69M$ 9.31M$ 8.57M$ 25.56M
Stockholders' Equity$ 20.63M$ 54.31M$ 86.01M$ 114.52M$ 134.48M
Cash Flow
Free Cash Flow$ -29.84M$ -29.90M$ -23.45M$ 5.14M$ 40.41M
Operating Cash Flow$ -29.14M$ -29.16M$ -22.08M$ 6.57M$ 41.08M
Investing Cash Flow$ 26.27M$ 17.07M$ 15.39M$ -58.17M$ 4.10M
Financing Cash Flow$ 11.81M$ 103.91K$ -1.36M$ -14.03M$ 450.40K
Currency in USD

Co-Diagnostics Earnings and Revenue History

Co-Diagnostics Debt to Assets

Co-Diagnostics Cash Flow

Co-Diagnostics Forecast EPS vs Actual EPS